Researchers have discovered that newer antihyperglycemic drugs with a reduced risk of causing hypoglycemia might also benefit heart health among patients with type 2 diabetes. Studies have determined that these agents could reduce major adverse cardiovascular event risk.
This study involved a review of 10 control trials including 92,400 people with type 2 diabetes. The analysis was done to compare the efficiency and safety of newer antihyperglycemic drugs with lowered hypoglycemia risk. Findings included a significantly lower risk of major adverse cardiovascular events. Additionally, there were 0.42% lower mean A1c levels among participants who received antihyperglycemic medications.
These findings were published in Diabetes, Obesity, and Metabolism on May 2, 2018.